Quality assessment of guidelines/consensuses on traditional Chinese medicine/integrated traditional Chinese and Western medicine diagnosis and treatment of nonalcoholic fatty liver disease

Ruimin JIAO; Jingjie ZHAO; Juanjuan LI; Wei CHEN; Chaoru HAN; Li LI; Chunjun XU; Hong YOU

doi:10.12449/JCH250309

Volume 41 Issue 3

Mar. 2025

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2025 > 41(3): 446-452

PDF( 936 KB)

Quality assessment of guidelines/consensuses on traditional Chinese medicine/integrated traditional Chinese and Western medicine diagnosis and treatment of nonalcoholic fatty liver disease

DOI: 10.12449/JCH250309

Ruimin JIAO^{1a, 3},
Jingjie ZHAO^{1a, 3},
Juanjuan LI^{1a, 3},
Wei CHEN⁴,
Chaoru HAN^1a,
Li LI⁵,
Chunjun XU^{5
,
,
,},
Hong YOU^{1b, 3
,
,
,}

1a.
Department of Traditional Chinese Medicine Beijing Friendship Hospital，Capital Medical University Beijing 100050 China
1b.
Liver Research Center Beijing Friendship Hospital，Capital Medical University Beijing 100050 China
2.
Clinical Center for Metabolic Associated Fatty Liver Disease，Capital Medical University，Beijing 100050，China
3.
Department of Acupuncture and Moxibustion （Division 2），Dongzhimen Hospital，Beijing University of Chinese Medicine，Beijing 101121，China
4.
Department of Liver Diseases，Beijing Hospital of Traditional Chinese Medicine，Capital Medical University，Beijing 100010，China

Research funding:

National Natural Science Foundation of China (82405192);

Beijing Key Project of Major Disease by Chinese Medicine and Western Medicine Fatty Liver (2023BJSZDYNJBXTGG-017);

Beijing High-level Public Health Technical Personnel Construction Project (Discipline backbone-03-40);

Capital’s Funds for Health Improvement and Research （CFH） (2022-2-20213);

Capital’s Funds for Health Improvement and Research （CFH） (2022-1-2021);

The Project of ‘Friendship Seed Plan’ Talent Project of Beijing Friendship Hospital, Capital Medical University (YYZZ202333)

More Information

Corresponding author: XU Chunjun， xu1409@sina.com （ORCID： 0000-0003-0834-0336）; YOU Hong， youhong30@sina.com （ORCID： 0000-0001-9409-1158）
Received Date: 2024-08-07
Accepted Date: 2024-09-23
Published Date: 2025-03-25

Abstract

Abstract

Objective To evaluate the methodological quality and reporting quality of published guidelines/consensuses on traditional Chinese medicine （TCM）/integrated traditional Chinese and Western medicine diagnosis and treatment of nonalcoholic fatty liver disease （NAFLD）， and to provide a basis for formulating guidelines/consensuses on TCM/integrated traditional Chinese and Western medicine diagnosis and treatment of NAFLD in the future. Methods Databases including PubMed， Embase， Web of Science， CNKI， Wanfang Data， and CBM and the websites of China Association of Chinese Medicine and China Association of Integrative Medicine were searched for related articles published up to September 1， 2024. Two clinical researchers independently assessed the methodological quality and reporting quality of the guidelines/consensuses on TCM/integrated traditional Chinese and Western medicine diagnosis and treatment of NAFLD by using Appraisal of Guidelines for Research and Evaluation Ⅱ （AGREE Ⅱ） and Reporting Items for Practice Guidelines in Healthcare （RIGHT）. Results A total of nine guidelines/consensuses were included after literature screening， with four guidelines and five expert consensuses. The scores of different domains assessed by AGREE Ⅱ for the nine guidelines/consensuses were as follows： scope and purpose （47.1%）， stakeholder involvement （41.0%）， rigor of development （21.6%）， clarity of presentation （40.2%）， applicability （19.0%）， and editorial independence （19.6%）. The recommendation level of the articles was B level （recommended after revision） for four articles and C level （not recommended） for five articles. The RIGHT assessment showed high reporting rates for “Basic Information” and “Background”， while other areas needed to be improved. Currently， there was no international standard for the guidelines/consensuses on TCM/integrated traditional Chinese and Western medicine diagnosis and treatment of NAFLD， and the quality of these guidelines/consensuses needed to be enhanced to ensure comprehensiveness and credibility. Conclusion There is still potential for improving the quality of guidelines/consensuses on TCM/integrated traditional Chinese and Western medicine diagnosis and treatment of NAFLD， and AGREE Ⅱ and RIGHT checklists should be strictly followed to ensure the fairness， scientific rigor， and transparency of these guidelines/consensuses.

FullText(HTML)

References(23)

References

[1]	Chinese Society of Heptology of the Chinese Medical Association. Guidelines for the prevention and treatment of metabolic dysfunction-associated(non-alcoholic) fatty liver disease(Version 2024)[J]. J Pract Hepatol, 2024, 27( 4): 494- 510. DOI: 10.3760/cma.j.cn501113-20240327-00163. 中华医学会肝病学分会. 代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)[J]. 实用肝脏病杂志, 2024, 27( 4): 494- 510. DOI: 10.3760/cma.j.cn501113-20240327-00163.
[2]	Branch of Hepatobiliary Diseases, Chinese Association of Chinese Medicine. Chinese medicine practice guide for acupoint catgut embedding in treating non-alcoholic fatty liver disease[J]. J Clin Hepatol, 2022, 38( 9): 1990- 1993. DOI: 10.3969/j.issn.1001-5256.2022.09.008. 中华中医药学会肝胆病分会. 穴位埋线治疗非酒精性脂肪性肝病中医实践指南[J]. 临床肝胆病杂志, 2022, 38( 9): 1990- 1993. DOI: 10.3969/j.issn.1001-5256.2022.09.008.
[3]	Digestive System Disease Professional Committee of the Chinese Society of Integrated Traditional Chinese and Western Medicine. Consensus on the diagnosis and treatment of non alcoholic fatty liver disease with integrated traditional Chinese and western medicine[J]. Chin J Integr Tradit West Med, 2011, 31( 2): 155- 158. DOI: 10.3969/j.issn.1671-038X.2018.01.01. 中国中西医结合学会消化系统疾病专业委员会. 非酒精性脂肪性肝病的中西医结合诊疗共识意见[J]. 中国中西医结合杂志, 2011, 31( 2): 155- 158. DOI: 10.3969/j.issn.1671-038X.2018.01.01.
[4]	Spleen and Stomach Diseases Branch of the China Association of Chinese Medicine. Consensus on Traditional Chinese Medicine Diagnosis and Treatment of Non alcoholic Fatty Liver Disease[J]. Beijing J Tradit Chin Med, 2011, 30( 2): 83- 86. DOI: 10.16025/j.1674-1307.2011.02.003. 中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗共识意见[J]. 北京中医药, 2011, 30( 2): 83- 86. DOI: 10.16025/j.1674-1307.2011.02.003.
[5]	Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of nonalcoholic fatty liver disease(2017)[J]. J Clin Hepatol, 2017, 33( 12): 2270- 2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002. 中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗专家共识意见(2017)[J]. 临床肝胆病杂志, 2017, 33( 12): 2270- 2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002.
[6]	Digestive System Disease Professional Committee of the Chinese Society of Integrated Traditional Chinese and Western Medicine. Consensus Opinion on the Diagnosis and Treatment of Non alcoholic Fatty Liver Disease with Integrated Traditional Chinese and Western Medicine(2017)[J]. Chin J Integr Tradit West Med Dig, 2017, 25( 11): 805- 811. DOI: 10.3969/j.issn.1671-038X.2017.11.02. 中国中西医结合学会消化系统疾病专业委员会. 非酒精性脂肪性肝病中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志, 2017, 25( 11): 805- 811. DOI: 10.3969/j.issn.1671-038X.2017.11.02.
[7]	Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Guidelines for Traditional Chinese Medicine Diagnosis and Treatment of Non alcoholic Fatty Liver Disease(Grassroots Doctor Edition)[J]. Chin J Integr Tradit West Med Liver Dis, 2019, 29( 5): 483- 486. 中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗指南(基层医生版)[J]. 中西医结合肝病杂志, 2019, 29( 5): 483- 486.
[8]	Diagnosis and Treatment Center of Hepatology of South China Alliance of TCM, National Administration of Traditional Chinese Medicine. Diagnosis and treatment scheme of Ganpi(non-alcoholic steatohepatitis[J/CD]. Chin J Liver Dis Electron Version, 2021, 13( 1): 1- 9. DOI: 10.3969/j.issn.1674-7380.2021.01.001. 国家中医药管理局华南区中医肝病诊疗中心联盟. 肝癖(非酒精性脂肪性肝炎)诊疗方案[J/CD]. 中国肝脏病杂志(电子版), 2021, 13( 1): 1- 9. DOI: 10.3969/j.issn.1674-7380.2021.01.001.
[9]	Branch of Hepatobiliary Diseases, China Association of Chinese Medicine. Diagnosis and treatment guideline for Chinese Medicine on non-alcoholic steatohepatitis[J]. J Clin Hepatol, 2023, 39( 5): 1041- 1048. DOI: 10.3969/j.issn.1001-5256.2023.05.007. 中华中医药学会肝胆病分会. 非酒精性脂肪性肝炎中医诊疗指南[J]. 临床肝胆病杂志, 2023, 39( 5): 1041- 1048. DOI: 10.3969/j.issn.1001-5256.2023.05.007.
[10]	ZHANG FQ, HU ZT, ZHANG YJ, et al. Methodology for the development of clinical practice guidelines for Chinese patent medicine(part 8): Quality evaluation with AGREE II and RIGHT[J]. J Tradit Chin Med, 2024, 65( 2): 185- 201. DOI: 10.13288/j.11-2166/r.2024.02.012. 张福强, 胡紫腾, 张钰菁, 等. 中成药临床实践指南制定方法(八): 基于AGREE II和RIGHT的中成药临床实践指南质量评价[J]. 中医杂志, 2024, 65( 2): 185- 201. DOI: 10.13288/j.11-2166/r.2024.02.012.
[11]	Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on Traditional Chinese Medicine diagnosis and treatment of non-alcoholic fatty liver disease(2023)[J]. Chin J Integr Tradit West Med Dig, 2024, 32( 1): 1- 7. 中华中医药学会脾胃病学会. 非酒精性脂肪性肝病中医诊疗专家共识(2023)[J]. 中国中西医结合消化杂志, 2024, 32( 1): 1- 7.
[12]	FAN JG, JIN Q. A great dilemma and challenge of renaming metabolic associated fatty liver disease[J]. J Southwest Med Univ, 2022, 45( 5): 373- 376. 范建高, 金倩. 代谢相关脂肪性肝病更名的困境与挑战[J]. 西南医科大学学报, 2022, 45( 5): 373- 376.
[13]	LIU JL, SUN JH. Renaming non-alcoholic fatty liver disease: From metabolic dysfunction-associated fatty liver heterogeneity to“different treatment for the same disease”[J]. Chin J Integr Tradit West Med Dig, 2024, 32( 5): 450- 454. DOI: 10.3969/j.issn.1671-038X.2024.05.15. 刘嘉玲, 孙劲晖. 非酒精性脂肪性肝病更名: 从代谢功能障碍相关脂肪肝异质性到“同病异治”[J]. 中国中西医结合消化杂志, 2024, 32( 5): 450- 454. DOI: 10.3969/j.issn.1671-038X.2024.05.15.
[14]	JIANG YR, CHEN KJ. Development and quality evaluation of evidence-based clinical practice guidelines of Chinese medicine[J]. Chin J Integr Tradit West Med, 2016, 36( 1): 11- 15. DOI: 10.7661/CJIM.2016.01.0011. 蒋跃绒, 陈可冀. 关于中医药循证临床实践指南的制定和质量评价[J]. 中国中西医结合杂志, 2016, 36( 1): 11- 15. DOI: 10.7661/CJIM.2016.01.0011.
[15]	SHAO JY, HU YH, YUAN WA, et al. Research progress on preparation technology and evaluation methods of Chinese medicine placebo[J]. Drug Eval Res, 2023, 46( 5): 1125- 1130. DOI: 10.7501/j.issn.1674-6376.2023.05.024. 邵靖渊, 胡薏慧, 元唯安, 等. 中药安慰剂制作工艺及评价方法的研究进展[J]. 药物评价研究, 2023, 46( 5): 1125- 1130. DOI: 10.7501/j.issn.1674-6376.2023.05.024.
[16]	GE L. Research progress on methodology of clinical practice guideline in the traditional Chinese medicine/integrative Chinese medicine field[J]. Chin J Drug Eval, 2022, 39( 4): 279- 284. DOI: 10.3969/j.issn.2095-3593.2022.04.001. 葛龙. 中医药/中西医结合临床实践指南制订方法学研究进展与展望[J]. 中国药物评价, 2022, 39( 4): 279- 284. DOI: 10.3969/j.issn.2095-3593.2022.04.001.
[17]	YAO YN, CAO KG, TUO T, et al. Construction of evidence grading and recommendation system for ancient Chinese medicine books through experts questionnaire survey[J]. J Tradit Chin Med, 2021, 62( 7): 572- 576. DOI: 10.13288/j.11-2166/r.2021.07.005. 姚钰宁, 曹克刚, 托托, 等. 基于专家问卷的中医古籍证据分级及推荐方法的构建[J]. 中医杂志, 2021, 62( 7): 572- 576. DOI: 10.13288/j.11-2166/r.2021.07.005.
[18]	LIANG CH, YIN DR, CUI J, et al. Application of ancient books in clinical practice guidelines and expert consensus of traditional Chinese medicine: Current status and methodological recommendations[J]. J Tradit Chin Med, 2024, 65( 8): 801- 809. DOI: 10.13288/j.11-2166/r.2024.08.007. 梁昌昊, 尹丁冉, 崔靖, 等. 中医药临床实践指南和专家共识中古籍证据应用情况分析及建议[J]. 中医杂志, 2024, 65( 8): 801- 809. DOI: 10.13288/j.11-2166/r.2024.08.007.
[19]	GAO YT, DONG XL, WANG Y, et al. Research approaches of patient values and preferences in traditional Chinese medicine clinical practice guidelines[J]. J Tradit Chin Med, 2022, 63( 9): 819- 824. DOI: 10.13288/j.11-2166/r.2022.09.005. 高胤桐, 董兴鲁, 王悦, 等. 中医临床实践指南中患者价值观与偏好要素的研究思路探讨[J]. 中医杂志, 2022, 63( 9): 819- 824. DOI: 10.13288/j.11-2166/r.2022.09.005.
[20]	GAO YC, XIA RY, CHAI QY, et al. Organizing patient panel: Suggestions on incorporating patient’s values and preferences into guideline development[J]. Med J Peking Union Med Coll Hosp, 2023, 14( 4): 875- 880. DOI: 10.12290/xhyxzz.2022-0528. 高一城, 夏如玉, 柴倩云, 等. 组建患者小组: 将患者价值观与偏好整合融入指南制订过程的建议[J]. 协和医学杂志, 2023, 14( 4): 875- 880. DOI: 10.12290/xhyxzz.2022-0528.
[21]	JIN TY, YAO Y, WU SH, et al. Literature quality evaluation of health economics of traditional Chinese medicine based on PEERs[J]. Guid J Tradit Chin Med Pharm, 2022, 28( 10): 167- 171, 176. DOI: 10.13862/j.cn43-1446/r.2022.10.039. 金同阳, 姚园, 吴少华, 等. 基于《药物经济学评价报告质量评估指南》的中医药卫生经济学研究文献质量评价[J]. 中医药导报, 2022, 28( 10): 167- 171, 176. DOI: 10.13862/j.cn43-1446/r.2022.10.039.
[22]	YAN LJ, LIANG N, ZHANG YJ, et al. Methodology for developing rapid and living guidelines of traditional Chinese medicine(RALIG-TCM)(part 4): Evidence monitoring and dynamic updates[J]. J Tradit Chin Med, 2024, 65( 3): 287- 291. DOI: 10.13288/j.11-2166/r.2024.03.011. 晏利姣, 梁宁, 张钰菁, 等. 中医药快速动态指南的制定方法(四): 证据监测与动态更新[J]. 中医杂志, 2024, 65( 3): 287- 291. DOI: 10.13288/j.11-2166/r.2024.03.011.
[23]	HE WW, AN Y, ZHANG LY, et al. Methodological problems and thinking in the process of formulating clinical practice guidelines of traditional Chinese medicine and expert consensus[J/OL]. China J Chin Med, 1- 9[ 2024-12-24]. http://kns.cnki.net/kcms/detail/41.1411.R.20240729. 1404.010.html. http://kns.cnki.net/kcms/detail/41.1411.R.20240729. 1404.010.html 何伟伟, 安莹, 张乐怡, 等. 中医临床实践指南与专家共识制订过程中存在的方法学问题与思考[J/OL]. 中医学报, 1- 9[ 2024-12-24]. http://kns.cnki.net/kcms/detail/41.1411.R.20240729. 1404.010.html. http://kns.cnki.net/kcms/detail/41.1411.R.20240729. 1404.010.html

Relative Articles

[1]	Wenxia ZHAO, Peiwei YANG. Effect and mechanism of external therapy of traditional Chinese medicine in treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(10): 1942-1948. doi: 10.12449/JCH241003
[2]	Drafting Group of Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Severe Acute Pancreatitis， Chinese Association of Traditional Chinese Medicine. Guidelines for integrated traditional Chinese and Western medicine diagnosis and treatment of severe acute pancreatitis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1114-1125. doi: 10.12449/JCH240608
[3]	Expert Committee on Hepatology， Doctor Society of Integrative Medicine， Chinese Medical Doctor Association. Expert consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2024, 40(5): 884-892. doi: 10.12449/JCH240507
[4]	Expert Committee on Hepatology， Doctor Society of Integrative Medicine， Chinese Medical Doctor Association. Experts consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1757-1766. doi: 10.12449/JCH240907
[5]	Chinese Society of Gastroenterology， Chinese Medical Association. Chinese consensus on clinical diagnosis and therapy of liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(9): 2057-2073.
[6]	Xiaodong ZHOU, Na TIAN, Minghua ZHENG. Excerpt of an international multidisciplinary consensus statement on MAFLD and the risk of CVD （2023）[J]. Journal of Clinical Hepatology, 2023, 39(10): 2336-2339. doi: 10.3969/j.issn.1001-5256.2023.10.010
[7]	Wenjing NI, Jie LI, Jiangao FAN. A brief introduction of AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease in 2023[J]. Journal of Clinical Hepatology, 2023, 39(5): 1049-1055. doi: 10.3969/j.issn.1001-5256.2023.05.008
[8]	Zhengwang ZHU, Pingsheng ZHU, Mingsan MIAO. Evaluation of cholestatic liver disease animal model based on clinical syndrome characteristics of integrated traditional Chinese and Western medicine[J]. Journal of Clinical Hepatology, 2023, 39(12): 2959-2964. doi: 10.3969/j.issn.1001-5256.2023.12.031
[9]	2019 Expert Committee on Clinical Coordination of Traditional Chinese and Western Medicine for Liver Cancer. Interventional expert consensus on integrated traditional Chinese and Western medicine for the diagnosis and treatment of hepatocellular carcinoma(trial editionⅠ)[J]. Journal of Clinical Hepatology, 2022, 38(1): 70-77. doi: 10.3969/j.issn.1001-5256.2022.01.010
[10]	National Science and Technology Major Project of the Ministry of Science and Technology of China-Prevention and Treatment of Major Infectious Diseases such as AIDS and Viral Hepatitis-Research Group of "Comprehensive Treatment Plan for Retarding Hepatitis B Related Liver Cancer Progression with Traditional Chinese Medicine", Oncology Expert Committee of Integrated Traditional Chinese and Western Medicine Branch of Chinese Medical Doctor Association, Digestive Rehabilitation Branch of Henan Rehabilitation Medical Association, Liver Disease Branch of Henan Society of Integrated Traditional Chinese and Western Medicine. Expert consensus on integrated traditional Chinese and Western medicine rehabilitation after transcatheter arterial chemoembolization for primary liver cancer[J]. Journal of Clinical Hepatology, 2021, 37(7): 1545-1549. doi: 10.3969/j.issn.1001-5256.2021.07.013
[11]	Chinese Association of Integrative Medicine. Expert consensus on the diagnosis and treatment of acute-on-chronic liver failure with integrated traditional Chinese and Western medicine[J]. Journal of Clinical Hepatology, 2021, 37(9): 2045-2053. doi: 10.3969/j.issn.1001-5256.2021.09.009
[12]	Xu Meng, Sun FengXia, Li Jie, Li XiaoLing. Research advances in the role of intestinal flora regulation in the traditional Chinese and Western medicine therapy for nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(6): 1378-1381. doi: 10.3969/j.issn.1001-5256.2020.06.041
[13]	Xue Rui, Fan JianGao. Brief introduction of an international expert consensus statement: A new definition of metabolic associated fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(6): 1224-1227. doi: 10.3969/j.issn.1001-5256.2020.06.007
[14]	Shang Dong, Zhang GuiXin, Zhang QingKai. Minimally invasive integrated traditional Chinese and Western medicine therapy for hepatolithiasis based on the SELECT concept[J]. Journal of Clinical Hepatology, 2020, 36(1): 31-35. doi: 10.3969/j.issn.1001-5256.2020.01.005
[15]	Li WenYi, Yuan ChengMin. Research advances in integrated traditional Chinese and Western medicine therapy for nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(4): 919-923. doi: 10.3969/j.issn.1001-5256.2020.04.047
[16]	Zhang Wei. Research advances in integrated traditional Chinese and Western medicine therapy for primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2018, 34(4): 698-703. doi: 10.3969/j.issn.1001-5256.2018.04.004
[17]	Chinese Society of EndocrinologyChinese Medical Association. Consensus for diagnosis and treatment of nonalcoholic fatty liver diseases and metabolic disorders (2nd Edition)[J]. Journal of Clinical Hepatology, 2018, 34(10): 2103-2108. doi: 10.3969/j.issn.1001-5256.2018.10.010
[18]	Guo ZeQi, Wang QianYi, Qi XingShun, Jia JiDong. Recommendations for the diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases (2017)[J]. Journal of Clinical Hepatology, 2017, 33(12): 2275-2277. doi: 10.3969/j.issn.1001-5256.2017.12.003
[19]	Wang Qin, Wei Lai. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease in children and adults in China and foreign countries:comparison and analysis[J]. Journal of Clinical Hepatology, 2017, 33(12): 2265-2269. doi: 10.3969/j.issn.1001-5256.2017.12.001
[20]	Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of nonalcoholic fatty liver disease (2017)[J]. Journal of Clinical Hepatology, 2017, 33(12): 2270-2274. doi: 10.3969/j.issn.1001-5256.2017.12.002

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(3)

Get Citation

PDF

XML

Article Metrics

Article views (61) PDF downloads(10)

Quality assessment of guidelines/consensuses on traditional Chinese medicine/integrated traditional Chinese and Western medicine diagnosis and treatment of nonalcoholic fatty liver disease

DOI: 10.12449/JCH250309

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content